MiNK Therapeutics, Inc. (INKT) - Quarterly Income Statement

Home
INKT
Financials

7.29 (USD) • At close May 13, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0	0	-11,708.192	0	0	11,708.192	2,704.743	1,562.759	1,559.312	0	221.92	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	1,884.612	0.045	0.054	0.054	5,223.561	6,343.344	5,854.096	0.038	7,987.349	7,698.431	7,374.289	0.024	13,376.434	0	0.016	0	0	0	0
Gross Profit Numbers are in millions	0	-1,884.612	-0.045	-0.054	-11,708.246	-5,223.561	-6,343.344	5,854.096	2,704.705	-6,424.59	-6,139.119	-7,374.289	221.896	-13,376.434	0	-0.016	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0	0	0.5	1	-4.111	-3.937	0	1	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	1.406	0.541	1.84	2.549	3.311	3.427	4.558	4.194	5.812	6.15	5.876	5.277	3.95	3.334	3.585	3.098	0.788	2.504	3.109	3.109
General & Administrative Expenses Numbers are in millions	0.809	1.163	1.062	1.28	2.189	1.796	1.785	1.661	2.077	1.838	1.822	2.097	2.362	0.815	0.868	0.595	-0.308	0.467	0.565	0.565
Selling & Marketing Expenses Numbers are in millions	0	0	0	-1,279.205	-0.054	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	0.809	1.163	1.062	1.227	2.135	1.796	1.785	1.661	2.077	1.838	1.822	2.097	2.362	0.815	0.868	0.595	-0.308	0.467	0.565	0.565
Other Expenses Numbers are in millions	0.288	0.181	0.169	0	-0	0	0	0	-0.015	1.563	1.559	-0.402	0.549	-9.592	-1.078	0.59	-0.369	-2.433	0	0
Operating Expenses Numbers are in millions	2.503	1.885	3.071	3.776	5.446	5.224	6.343	5.854	7.889	7.987	7.698	7.374	6.312	4.149	4.453	3.693	0.479	2.971	3.773	3.773
Operating Income Numbers are in millions	-2.503	-1.885	-3.071	-3.83	-5.5	-5.224	-6.343	-5.854	-7.889	-7.987	-7.698	-7.374	-6.362	-13.376	-5.612	-3.008	-1.525	-5.924	-3.673	-3.673
Operating Income Ratio Numbers are in millions	0	0	0	0	0	0	0	-0.001	-0.003	-0.005	-0.005	0	-0.029	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0.04	0.078	0.369	0.017	0.041	0.107	0.146	0.168	0.119	1.656	1.586	-0.403	0.597	-0.891	-0.723	-0.838	-0.01	-0.119	-0.736	-0.736
Income Before Tax Numbers are in millions	-2.463	-1.807	-2.702	-3.813	-5.459	-5.116	-6.197	-5.686	-7.77	-6.332	-6.113	-7.777	-5.764	-14.267	-6.335	-3.846	-1.535	-6.043	-4.33	-4.33
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	0	0	-0	-0.003	-0.004	-0.004	0	-0.026	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	0	-0	-0.107	6,489.587	-168.223	-0.28	-1.749	-1.612	0.403	0.002	-8.711	0.805	1.334	0.318	-1.794	0	0
Net Income Numbers are in millions	-2.463	-1.807	-2.702	-3.813	-5.459	-5.116	-6.197	162.537	-7.49	-4.583	-4.501	-8.18	-5.764	-14.267	-6.335	-3.846	-1.535	-6.043	-4.33	-4.33
Net Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0.014	-0.003	-0.003	-0.003	0	-0.026	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.065	-0.46	-0.073	-0.11	-0.16	-0.15	-0.18	4.79	-0.22	-0.14	-0.13	-0.24	-0.18	-0.43	-0.22	-0.14	-0.054	-0.21	-0.18	-0.18
EPS Diluted Numbers are in millions	-0.065	-0.046	-0.073	-0.11	-0.16	-0.15	-0.18	4.79	-0.22	-0.14	-0.13	-0.24	-0.18	-0.43	-0.22	-0.14	-0.054	-0.21	-0.18	-0.18
EBITDA Numbers are in millions	-2.161	-1.822	-2.857	-3.776	-5.447	-5.17	-6.291	-5.808	-7.851	-7.959	-7.67	-7.347	-5.741	-13.365	-5.595	-3.086	-0.832	-5.389	-3.661	-3.661
EBITDA Ratio Numbers are in millions	0	0	0	0	0	0	0	-0	-0.003	-0.005	-0.005	0	-0.026	0	0	0	0	0	0	0

MiNK Therapeutics, Inc.

NASDAQ:INKT Add to watchlist

NASDAQ:INKT